La Guajira assembly acknowledges Cerrejón’s support during COVID-19 emergency

Cerrejón was publicly recognized by the Departmental Assembly of La Guajira for its contribution to managing the crisis caused by the COVID-19 pandemic. The Assembly stressed the good coordination between the Departmental Administration and the productive sector in optimising resources aimed at reducing risks and increasing prevention, action, protection, and biosafety measures, safeguarding the lives of Guajirans and the inhabitants of the department.

“Today we present resolution 020 of 2021, by which the Assembly of La Guajira makes public recognition of the Cerrejón multinational for contributions facing the current crisis and for its social responsibility to the inhabitants of the department of La Guajira. Thank you very much to Claudia Bejarano Gutiérrez, president of the Cerrejón multinational, for her high level of commitment to the department of La Guajira. Thank you very much”, said Delay Magdaniel, Member of the Departmental Assembly.

To support La Guajira during the emergency, Cerrejón has invested USD 1.4 million in humanitarian assistance, translated into support for the health sector with the donation of the first molecular biology laboratory in the region, delivery of 100,000 medical supplies that have made it possible for professionals to have protective items for daily work, and delivery of three mechanical respirators and more than 400 pieces of equipment including stretchers and foetal or cardiac monitors, among other things, as well as the donation of 13,500 tests, between PCR and serological, for preventive analysis. As to community support, the company delivered more than 50,000 mercados (food/hygiene parcels), more than 29 million litres of drinking water, and protective items such as face masks and alcohol.

Cerrejón recently announced a donation to the La Guajira government of two ultralow-temperature freezers, to store COVID-19 vaccines, and an electric plant that guarantees permanent operation of the equipment and prompt availability of vaccines.